Dr Trevor Lockett is a molecular biologist by trade. He has over 30 years of research experience, predominantly at the CSIRO, and has led research efforts in the areas of prostate cancer gene therapy, colorectal cancer prevention and the promotion of gastrointestinal health.
As theme leader of Colorectal Cancer and Gut Health, Dr Lockett oversaw the research efforts leading to the technology that is to become ColoSTAT, a product of Rhythm Biosciences where he sits on the board as technical director.
Dr Lockett received his PhD in Biochemistry from the University of Adelaide, and postdoctoral experience at the Rockefeller University in New York.